| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-100 |
Sentence |
denotes |
Intracellular accumulation of secreted proteoglycans inhibits cationic lipid-mediated gene transfer. |
| T2 |
101-150 |
Sentence |
denotes |
Co-transfer of glycosaminoglycans to the nucleus. |
| T3 |
151-253 |
Sentence |
denotes |
Molecules secreted by potential target cells may interfere with cationic lipid-mediated gene transfer. |
| T4 |
254-344 |
Sentence |
denotes |
This has been studied using human lung fibroblasts and human epidermoid lung cancer cells. |
| T5 |
345-517 |
Sentence |
denotes |
Secreted cell medium components caused a substantial decrease both in the uptake of cationic lipid-DNA complexes (2-4-fold) and in reporter gene expression (100-1000-fold). |
| T6 |
518-667 |
Sentence |
denotes |
Metabolic labeling of the cell medium showed that especially [35S]sulfate-labeled macromolecules competed with DNA for binding to the cationic lipid. |
| T7 |
668-793 |
Sentence |
denotes |
Release of DNA from the cationic lipid by cell medium components was demonstrated by an ethidium bromide intercalation assay. |
| T8 |
794-892 |
Sentence |
denotes |
In the presence of the cationic lipid, the secreted macromolecules were internalized by the cells. |
| T9 |
893-1155 |
Sentence |
denotes |
By enzymatic digestions, it was shown that the competing macromolecules consist of chondroitin/dermatan sulfate and heparan sulfate proteoglycans and that the effects on transfection were mediated by the polyanionic glycosaminoglycan portion of the proteoglycan. |
| T10 |
1156-1295 |
Sentence |
denotes |
Accordingly, pretreatment of cell medium with the polycationic peptide protamine sulfate abrogated the inhibitory effects on gene transfer. |
| T11 |
1296-1438 |
Sentence |
denotes |
Fluorescence microscopy studies revealed that heparan sulfate, internalized as a complex with cationic lipids, accumulated in the cell nuclei. |
| T12 |
1439-1603 |
Sentence |
denotes |
These results support the view that the lack of specificity of this type of gene transfer vehicle is a major hindrance to efficient and safe in vivo administration. |